Yuh Min (Johnson) Chiang
About Yuh Min (Johnson) Chiang
Yuh-Min (Johnson) Chiang Senior Vice President R&D and Product Development
Yuh-Min (Johnson) Chiang serves as the Senior Vice President of R&D and Product Development. His role focuses on advancing research and driving innovative product development initiatives within the organization. With a robust background in biotechnology and medical device industries, Chiang's leadership is pivotal in spearheading new technological advancements.
Education and BioMEMS Expertise of Yuh-Min (Johnson) Chiang
Yuh-Min (Johnson) Chiang holds a Ph.D. degree specializing in BioMEMS (Micro Electro-Mechanical Systems) from the University of California, Irvine. Additionally, he earned a Master's degree in Engineering from The Ohio State University and a Bachelor's degree in Applied Chemistry from National Chiao Tung University, Taiwan. His academic foundation in engineering and chemistry underpins his extensive expertise in the biotechnology sector.
Professional Background of Yuh-Min (Johnson) Chiang
Yuh-Min (Johnson) Chiang has held several key positions within leading biotechnology companies. He was previously the Chief Technology Officer at Alveo Technologies, where he directed the development of the COVID-19 be.well Test, achieving significant regulatory milestones. Chiang also contributed to major advancements at Foundation Medicine, Inc., Life Technologies, Thermo Fisher Scientific, and Cepheid, where he guided systems design, integration, and compliance processes.
Achievements of Yuh-Min (Johnson) Chiang
During his tenure at various organizations, Yuh-Min (Johnson) Chiang has facilitated the fundraising of approximately $50MM and demonstrated his capability by winning the XPrize Grand Award for Rapid Covid Testing. He has been instrumental in bringing several key products from concept to commercialization, navigating complex regulatory environments, and achieving critical approvals such as the CE mark and UK approval for the COVID-19 be.well Test. Chiang's contributions are underscored by numerous biotechnology papers and patents.